Avricore Health Inc. (TSXV: AVCR)
AVCR trades on the TSX Venture Exchange in Life Sciences, headquartered in British Columbia. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of September 30, 2026. US$ figures convert C$ at 1.4263 C$ per US$, the Bank of Canada daily rate for October 14, 2026. Close and returns: Yahoo Finance daily closes for AVCR.V, last bar 2026-10-13, computed by Sophia Capital.
Profile
| Field | Value |
|---|---|
| Ticker | AVCR on the TSX Venture Exchange |
| Yahoo symbol | AVCR.V |
| Sector | Life Sciences |
| Headquarters | British Columbia |
| Listed | 2001-07-31 |
| Listing type | TMX leaves listing type blank for long-listed issuers |
| Shares outstanding | 126,369,664 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | 0001355736 |
| Website | No company website on record |
Returns
| Window | Return |
|---|---|
| 1 day | 0.0% |
| 1 week | -8.3% |
| 1 month | -8.3% |
| 3 months | -8.3% |
| 6 months | -15.4% |
| Year to date | +10.0% |
| 1 year | -26.7% |
| From 52-week high | -38.9% |
| 52-week range | C$0.0450 to C$0.0900 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
72 documents in 8 types. Each title links to the document at its source.
Interim financial statements (2)
| Document | Type | Filed |
|---|---|---|
| Interim financial statements report for September 30, 2025 | Interim financial statements (6-K) | 2026-01-12 |
| Interim Financial Statements | Interim financial statements (6-K) | 2024-12-05 |
MD&A (5)
| Document | Type | Filed |
|---|---|---|
| Annual MD&A | MD&A (annual) (6-K) | 2026-05-11 |
| Annual MD&A | MD&A (annual) (6-K) | 2025-05-20 |
| Interim MD&A for March 31, 2026 | MD&A (interim) (6-K) | 2026-07-13 |
| Interim Management Discussion and Analysis | MD&A (interim) (6-K) | 2025-09-15 |
Material change report (1)
| Document | Type | Filed |
|---|---|---|
| Material change report | Material change report (6-K) | 2026-09-17 |
News release (7)
| Document | Type | Filed |
|---|---|---|
| News Release - Avricore Grants Options | News release (6-K) | 2026-09-17 |
| News Release - Avricore Health Announces $1.25 Million Financing | News release (6-K) | 2026-06-11 |
| News Release- Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform | News release (6-K) | 2026-05-11 |
| News Release-Avricore appoints Roger Seccombe CEO | News release (6-K) | 2025-07-11 |
Management information circular / proxy (5)
| Document | Type | Filed |
|---|---|---|
| Management information circular-Notice of AGM | Management information circular (6-K) | 2025-07-11 |
| Notice of Meeting – Notice of AGM to be Held on June 18, 2026 | Notice of meeting (6-K) | 2026-06-11 |
| Notice of the meeting and record date (Amended) | Notice of meeting (6-K) | 2025-06-05 |
| Notice of the meeting and record date | Notice of meeting (6-K) | 2025-05-20 |
Annual report (1)
| Document | Type | Filed |
|---|---|---|
| 20-F Period 2024-12-31 | Annual report (20-F) (20-F) | 2025-06-16 |
Certification (11)
| Document | Type | Filed |
|---|---|---|
| 52-109FV1 - Certification of annual filings - CEO | Certification (52-109F1) (6-K) | 2026-05-11 |
| Form 52-109 FV1-Certification of Interim Filings CEO | Certification (52-109F1) (6-K) | 2025-06-05 |
| Form 52-109 FV1-Certification of Annual Filings CEO | Certification (52-109F1) (6-K) | 2025-05-20 |
| 52-109FV2 - Certification of interim filings - CFO | Certification (52-109F2) (6-K) | 2026-09-17 |
Other (40)
| Document | Type | Filed |
|---|---|---|
| EX-5 | Consent (6-K) | 2026-09-17 |
| EX-5 | Consent (6-K) | 2026-07-13 |
| EX-5 | Consent (6-K) | 2026-06-11 |
| EX-8 | Consent (6-K) | 2026-06-11 |
Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| MUSH | Mercanto Holdings Inc. | TSXV | C$6.3M | -8.3% | +46.7% |
| KNE | Kane Biotech Inc. | TSXV | C$6.2M | -16.7% | -37.5% |
| JUMP | LevelJump Healthcare Corp. | TSXV | C$6.1M | 0.0% | -15.4% |
| TELO | Telo Genomics Corp. | TSXV | C$5.0M | +55.6% | +7.7% |
| MRVL | Marvel Biosciences Corp. | TSXV | C$9.8M | -26.7% | -51.1% |
The app has the price chart, every filing, private raises and the full peer set for AVCR.
Open in the app